Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

BB146404 Inhibitors

Chemical inhibitors of BB146404 encompass a range of compounds that disrupt various signaling pathways and cellular processes, consequently inhibiting the function of this protein. Staurosporine serves as a broad-spectrum protein kinase inhibitor and can inhibit BB146404 by targeting its kinase activity directly, assuming that BB146404 has kinase activity or interacts with protein kinases. LY294002 and Wortmannin, both PI3K inhibitors, can inhibit BB146404 by disrupting the PI3K/Akt signaling pathway, which is pivotal for cell survival and proliferation, thereby impacting the functional role of BB146404 within this pathway. Similarly, PD98059 and U0126, which are specific MEK inhibitors, can inhibit BB146404 by obstructing the MAPK/ERK pathway, a critical route for cell cycle control and differentiation, possibly linked with BB146404's activity.

Further, SB203580 and SP600125, which inhibit p38 MAPK and JNK respectively, can inhibit BB146404 by impeding the signaling pathways responsible for stress responses and apoptosis that may involve BB146404. Rapamycin, an mTOR inhibitor, can inhibit BB146404 by blocking the mTORC1 complex within the mTOR signaling pathway, which is significant for cell growth and protein synthesis. Bortezomib, by inhibiting the proteasome, can inhibit BB146404 by stabilizing proteins that control apoptosis, cell cycle, and growth, potentially affecting the regulatory role of BB146404. ZM-447439 targets Aurora kinases and can inhibit BB146404 by disrupting chromosome alignment and segregation during cell division, processes that BB146404 may influence. Sotrastaurin, by selectively inhibiting PKC, can inhibit BB146404 by altering PKC-mediated signal transduction, which may be relevant to BB146404's role in cellular differentiation and proliferation. Lastly, AG-490, as a JAK2 inhibitor, can inhibit BB146404 by interfering with the JAK/STAT signaling pathway, which is crucial for regulating cell growth and immune response, indicating the potential involvement of BB146404 in these processes.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A potent non-selective inhibitor of protein kinases, Staurosporine can inhibit BB146404 by impeding its kinase activity, assuming BB146404 possesses or interacts with kinase domains.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A specific inhibitor of PI3K, LY294002 can inhibit BB146404 by disrupting the PI3K/Akt signaling pathway, which may be crucial for BB146404's function related to cell survival and growth.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Similarly a PI3K inhibitor, Wortmannin can inhibit BB146404 by blocking the PI3K pathway, leading to reduced Akt phosphorylation and activity, potentially impacting BB146404's role in this pathway.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An MEK inhibitor, PD98059 can inhibit BB146404 by preventing the activation of the MAPK/ERK pathway, which could be essential for BB146404's function if it is involved in this signaling cascade.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

This p38 MAPK inhibitor can inhibit BB146404 by blocking the p38 MAPK signaling pathway, which is involved in stress responses, and may be important for BB146404's activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, SP600125 can inhibit BB146404 by hindering the JNK signaling pathway, which can regulate apoptosis and cellular proliferation, possibly related to the activity of BB146404.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

By inhibiting MEK1/2, U0126 can inhibit BB146404 by disrupting the MEK/ERK pathway, which may be a pathway that BB146404 is part of, affecting its role in cell cycle regulation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor, Rapamycin can inhibit BB146404 by blocking the mTOR signaling pathway, potentially impacting protein synthesis and growth signals that BB146404 could be influencing.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

As a proteasome inhibitor, Bortezomib can inhibit BB146404 by preventing the degradation of regulatory proteins that control cell cycle, growth, and apoptosis, processes that BB146404 may regulate.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$150.00
$349.00
15
(1)

An Aurora kinase inhibitor, ZM-447439 can inhibit BB146404 by preventing phosphorylation events necessary for chromosome alignment and segregation, which could be critical for BB146404's function in cell division.